Avenant Tech和Ainnova Tech正在开发人工智能血液测试,用于早期痴呆症检测。 Avant Technologies and Ainnova Tech are developing an AI blood test for early dementia detection.

Avenant Tech和Ainnova Tech正在探索将早期痴呆症检测纳入Ainnova的AI动力筛查平台, Avant Technologies and Ainnova Tech are exploring the integration of early dementia detection into Ainnova's AI-powered screening platform, Vision AI. 这些公司已经确定了一种有前途的技术,使用人工智能和5分钟的血液测试来早期检测痴呆症。 The companies have identified a promising technology that uses AI and a 5-minute blood test for early dementia detection. 如果加以整合,就可以扩大其在早期疾病发现和预防保健解决方案方面的全球服务。 If integrated, this could expand their global offerings in early disease detection and preventative health solutions.